Search clinical trials for: galantamine HBr

Total 1241 results

GlaxoSmithKline

Active, not recruiting

Safety, Efficacy, Immunogenicity Study of GSK Biologicals' HBV Viral Vector and Adjuvanted Proteins Vaccine (GSK3528869A) in Adult Patients With Chronic Hepatitis B Infection

Hepatitis B, Chronic

Taiwan, Belgium, Thailand, Germany, Spain, Hong Kong, United Kingdom, France, Poland
Xian-Janssen Pharmaceutical Ltd.

Completed

A Randomized, Double-blind, Flexible Dose, Multicenter Study to Evaluate the Effectiveness and Safety of Galantamine IR in Mild to Moderate Alzheimer's Disease

Alzheimer Disease
Massachusetts General Hospital

Completed

A Double-Blind Comparison of Galantamine HBr and Placebo in Adults With Attention Deficit Hyperactivity Disorder

ADHD

United States
University of Michigan

Completed

The "Open Wound Bone Augmentation Concept" With Amnion-Chorion Membrane

Horizontal Ridge Deficiency

United States
Dayton Children's Hospital
United States Department of Defense; Kettering Health Network

Terminated

An Evaluation of Hyperbaric Treatments for Children With Cerebral Palsy

Cerebral Palsy | Cerebral Palsy, Spastic

United States
American Academy of Pediatrics
University of North Carolina, Chapel Hill; Thrasher Research Fund; RTI International and other collaborators

Completed

Newborn Heart Rate as a Catalyst for Improved Survival

Stillbirth | Neonatal Resuscitation | Neonatal Respiratory Depression | Neonatal Bradycardia

Congo, The Democratic Republic of the
Spero Therapeutics
Covance

Completed

Study of the Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) Following a Single Oral Dose in Healthy Male Subjects

Healthy Volunteers

United States
Spero Therapeutics

Completed

Phase 1 Study of PK and Safety of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Subjects With Various Degrees Of Renal Function

Renal Impairment

United States
Spero Therapeutics
Clinartis

Completed

Study to Assess the Intrapulmonary Pharmacokinetics of SPR859 by Comparing the Plasma, Epithelial Lining Fluid (ELF), and Alveolar Macrophages (AM) Concentrations Following the Oral Administration of Five Doses of SPR994 in Healthy, Nonsmoking Volunteers

Healthy Volunteers

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

A Study to Help People Quit Smoking.

Nicotine Dependence

United States
Spero Therapeutics

Completed

Bioequivalence Study Comparing Two Tablet Formulations of Tebipenem Pivoxil Hydrobromide (TBPM-PI-HBr) in Healthy Adult Subjects

Healthy Volunteers

United States
Spero Therapeutics

Completed

A Study to Compare Two Bioanalytical Assays for Tebipenem

Healthy Volunteers

United States
Samsung Medical Center
Janssen Korea, Ltd., Korea

Completed

Characteristics of Treatment Responders to Galantamine

Dementia

Korea, Republic of
Ludwig-Maximilians - University of Munich

Unknown

Diffusion Tensor Weighted MRI in Alzheimer's Disease Modifying Treatment Effects of Galantamine (Reminyl®)

Alzheimer's Disease

Germany
Icahn School of Medicine at Mount Sinai
National Institute of Mental Health (NIMH); Massachusetts General Hospital

Completed

Efficacy and Safety of Galantamine for Improving Dysfunction in People With Bipolar Disorder

Bipolar Disorder

United States
The University of Texas Health Science Center,...

Completed

Subarachnoid Hemorrhage Recovery And Galantamine (SAHRANG)

Subarachnoid Hemorrhage

United States
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

Alzheimer's Disease

Japan
Actavis Inc.

Completed

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions

Healthy

Canada
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia

Dementia, Vascular
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Long-term Safety and Efficacy of Galantamine in Alzheimer's Disease

Alzheimer Disease
Actavis Inc.

Completed

Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Urmia University of Medical Sciences

Completed

Increasing Atrial Base Rate Pacing to Reduce Atrial Fibrillation

Paroxysmal Atrial Fibrillation | Sick Sinus Syndrome

Iran, Islamic Republic of
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia

Frontotemporal Dementia | Pick Complex
Janssen Pharmaceutical K.K.

Completed

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease.

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

A Study of the Effects on Sleep, Attention, and Gastrointestinal Tolerance of Galantamine and Donepezil in Patients With Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Placebo-Controlled Evaluation of Galantamine in the Treatment of Alzheimer's Disease: Safety and Efficacy of a Controlled-Release Formulation

Dementia | Alzheimer Disease
Parkinson's Disease and Movement Disorders Center
Ortho-McNeil Neurologics, Inc.

Terminated

Safety Study of Galantamine in Tic Disorders

Tourette's Syndrome | Motor Tic Disorder | Vocal Tic Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...
Ortho-McNeil Neurologics, Inc.

Completed

Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease

Alzheimer's Disease
Xian-Janssen Pharmaceutical Ltd.

Completed

A Single Dose, Cross-over Bioequivence Study Comparing Galantamine IR (Immediate Release) Table and Galantmine OS (Oral Solution) in Healthy Volunteers

Pharmacokinetics
Bristol-Myers Squibb

Completed

Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)

Alzheimer Disease

United States
North Suffolk Mental Health Association
Janssen Medical Affairs

Completed

Galantamine for Cognition in People With Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Janssen Cilag Pharmaceutica S.A.C.I., Greece

Completed

A Study of the Safety and Effectiveness of Galantamine Hydrobromide in Patients With Alzheimer's Disease

Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Galantamine Versus Placebo in the Treatment of Patients With Vascular Dementia or Mixed Dementia

Alzheimer Disease | Vascular Dementia
University of Sao Paulo
University of Nove de Julho; Feinstein Institute for Medical Research

Completed

Galantamine Effects in Patients With Metabolic Syndrome (GALANTA-MS)

Abdominal Obesity Metabolic Syndrome

Brazil
Janssen Pharmaceutica N.V., Belgium

Completed

Treatment of Severe Alzheimer's Disease: Evaluation of Efficacy and Safety of Galantamine Hydrobromide in a Controlled Study

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.

Alzheimer's Disease
Memorial Hospital of Rhode Island
Ortho-McNeil Neurologics, Inc.

Unknown

Galantamine Executive Function in Parkinson's Disease

Parkinson's Disease

United States
University of Maryland, Baltimore
Stanley Medical Research Institute; Ortho-McNeil Neurologics, Inc.

Completed

Efficacy Study of Galantamine for Cognitive Impairments in Schizophrenia

Schizophrenia | Schizoaffective Disorder

United States
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment

Dementia | Alzheimer Disease
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment

Mental Disorders | Brain Diseases | Nervous System Diseases | Cognition Disorder
Janssen-Cilag S.p.A.

Completed

A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease

Mental Disorders | Brain Diseases | Dementia | Alzheimer Disease
Janssen Korea, Ltd., Korea

Completed

The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type

Alzheimer Disease
Massachusetts General Hospital

Completed

Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder

Bipolar Disorder

United States
Janssen-Cilag Pty Ltd

Completed

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

Dementia | Alzheimer Disease | Galantamine

Australia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease

Dementia | Alzheimer Disease
Seattle Institute for Biomedical and Clinical Research

Terminated

Efficacy of Galantamine to Treat Schizophrenia

Schizophrenia | Psychotic Disorder

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study

Migraine Without Aura | Migraine With Aura

Spain, France, Italy, Netherlands, Turkey, Belgium, Hungary, Czechia, Denmark, Germany, Greece, Norway, Portugal, Sweden
Johnson & Johnson Pharmaceutical Research & Development...
Shire

Completed

Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease

Dementia | Alzheimer's Disease

Search clinical trials for: galantamine HBr

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Germany

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations